About Vala Sciences
Vala Sciences is a Healthcare company based in San Diego (United States) founded in 2004. Cell-image-based instrumentation, high content screening services, reagents and analysis software tools. Vala Sciences has raised $2 million across 25 funding rounds from investors including HHS. Vala Sciences offers products and services including KIC® Kinetic Image Cytometer®, CyteSeer®, ValaDATE™ AI Platform, and SIM® Structured Illumination Microscopy. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified. Its legal entity is Vala Sciences, Inc. Its competitors include Quanterix, Biocare Medical and BioLife Solutions; 2 of its 3 listed competitors have raised funding.
Company details
Vala Sciences is a biotechnology company that develops and sells cell-image-based instrumentation, high content screening services, reagents, and analysis software tools to academic, pharmaceutical and biotechnology scientists. The companys technologies enable information-rich measurements for making new insights into the cell functions critical to progress in the biological sciences. They provide varied and validated high content screening services that quantify the effects of compound libraries on a number of target molecules. They also offer cardiotoxicity screens with their Kinetic Image Cytometer (KIC) and software, which allows for live imaging of cardiomyocytes and provides robust data for identifying pro-arrhythmic compounds early in drug discovery.
- Headquarters San Diego, United States
- SectorsHealthcare
- Website valasciences.com
- Social LinkedIn X
- Legal Name Vala Sciences, Inc.
- Total Equity Funding$2M (USD)
in 25 rounds
- Latest Funding Round$1.22M (USD), Grant
Jun 2024
- Investors
Products & Services of Vala Sciences
Vala Sciences offers a comprehensive portfolio of products and services, including KIC® Kinetic Image Cytometer®, CyteSeer®, ValaDATE™ AI Platform, and SIM® Structured Illumination Microscopy.
Automated system for real-time cell kinetics video analysis
Platform for extracting and parameterizing cell transient data
Tool for assessing toxicity and efficacy from cell data
High-resolution imaging for drug screening applications
Funding Insights of Vala Sciences
Vala Sciences has successfully raised a total of $2M across 25 strategic funding rounds. The most recent funding activity was a Grant round of $1.22 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 25
- Last Round Grant — $1.22M
- First Round $3.08M
(Jul 2006)
- Investors Count 1
Latest 10 of 25 funding rounds of Vala Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $1.22M | Grant | – | – | |
| Sep 2023 | $2.06M | Grant | – | – | |
| Jun 2021 | $2.76M | Grant | – | – | |
| Sep 2018 | $301,078 | Grant | – | – | |
| Sep 2018 | $224,018 | Grant | – | – | |
| Sep 2018 | $2.22M | Grant | – | – | |
| May 2017 | $2M | Series A | – | – | – |
| Sep 2015 | $2.23M | Grant | – | – | |
| Sep 2013 | $1.72M | Grant | – | – | |
| Jun 2013 | $488,566 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Vala Sciences
Vala Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Vala Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vala Sciences
6 people are tracked at Vala Sciences (6 in leadership).
| Name | Role | Group |
|---|---|---|
Jeffrey Price | President and CEO | Leadership |
Randy Ingermanson | Director of Software Engineering | Leadership |
Heather Pelton | Director of Finance And Operations | Leadership |
Pat McDonough | VP of Biological Studies | Leadership |
Ramses Agustin | Director of Applications & Support | Leadership |
Ranor C. B. Basa | Director Of Assay Development And Screening Services | Leadership |
Complete people profiles for Vala Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vala Sciences
3 dated milestones of Vala Sciences across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Vala Sciences is founded.
- Funding First funding round of $3.1M.
- Funding Latest funding round, Grant, of $1.2M.
Competitors of Vala Sciences
Vala Sciences has 3 listed competitors in our database, 2 of them funded. They include Quanterix, Biocare Medical and BioLife Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. |
Detailed competitors of Vala Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Vala Sciences
Websites that share an audience with Vala Sciences (valasciences.com).
Websites whose visitors overlap most with Vala Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
validation.org | validation.org | 100% | #9,714,983 | – | |
| arthrosi.com | 87% | 4.1K | #4,683,702 | View details | |
biopioneerinc.com | biopioneerinc.com | 85% | #5,300,424 | – | |
| businesstalentgroup.com | 81% | 58.5K | #500,355 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Vala Sciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vala Sciences
Vala Sciences was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Vala Sciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Vala Sciences is a funded company, having raised a total of $2M across 25 funding rounds to date. The company's 1st funding round was a Grant of $488.57K, raised on Jul 2006.
Vala Sciences is a biotechnology company that develops and sells cell-image-based instrumentation, high content screening services, reagents, and analysis software tools to academic, pharmaceutical and biotechnology scientists. The companys technologies enable information-rich measurements for making new insights into the cell functions critical to progress in the biological sciences. They provide varied and validated high content screening services that quantify the effects of compound libraries on a number of target molecules. They also offer cardiotoxicity screens with their Kinetic Image Cytometer (KIC) and software, which allows for live imaging of cardiomyocytes and provides robust data for identifying pro-arrhythmic compounds early in drug discovery.
Vala Sciences's top competitors include Biocare Medical, Quanterix and BioLife Solutions.
Vala Sciences offers KIC® Kinetic Image Cytometer®, CyteSeer®, ValaDATE™ AI Platform, and SIM® Structured Illumination Microscopy.
Vala Sciences has 1 investor. Key investors include HHS.
Vala Sciences operates through Vala Sciences, Inc..